ClinicalTrials.gov
ClinicalTrials.gov Menu

A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00922883
Recruitment Status : Active, not recruiting
First Posted : June 17, 2009
Last Update Posted : October 19, 2017
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : May 7, 2013
  Estimated Study Completion Date : December 31, 2020
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):